We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Staining of U-2 OS FUCCI cells, to characterize the cell cycle dependency of the protein expression pattern. The FUCCI cells, Fluorescence Ubiquitination Cell Cycle Indicator, are cells tagged with different fluorescent proteins fused to two different cell cycle regulators Cdt1 (expressed in G1 phase) and Geminin (expressed in S and G2 phases) that allows cell cycle monitoring. When both proteins are present, the overlay of the images appear in yellow marking the G1/S transition. TOP2A is mostly expressed during S and/or G2, and during Mitosis.
CELL CYCLE
Summary
Expression has cell cycle dependency according to custom assay
Intensity variation
Nucleoli, Nucleus
GENE INFORMATION
Gene name
TOP2A (HGNC Symbol)
Synonyms
TOP2
Description
Topoisomerase (DNA) II alpha (HGNC Symbol)
Entrez gene summary
This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. [provided by RefSeq, Jul 2010]
Enzymes ENZYME proteins Isomerase Predicted intracellular proteins Plasma proteins Cancer-related genes Candidate cancer biomarkers FDA approved drug targets Small molecule drugs Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000228 [nuclear chromosome] GO:0000278 [mitotic cell cycle] GO:0000287 [magnesium ion binding] GO:0000712 [resolution of meiotic recombination intermediates] GO:0000793 [condensed chromosome] GO:0000819 [sister chromatid segregation] GO:0002244 [hematopoietic progenitor cell differentiation] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003918 [DNA topoisomerase type II (ATP-hydrolyzing) activity] GO:0005080 [protein kinase C binding] GO:0005515 [protein binding] GO:0005524 [ATP binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0005814 [centriole] GO:0006265 [DNA topological change] GO:0006266 [DNA ligation] GO:0006268 [DNA unwinding involved in DNA replication] GO:0006974 [cellular response to DNA damage stimulus] GO:0007059 [chromosome segregation] GO:0008022 [protein C-terminus binding] GO:0008094 [DNA-dependent ATPase activity] GO:0008144 [drug binding] GO:0008301 [DNA binding, bending] GO:0009330 [DNA topoisomerase complex (ATP-hydrolyzing)] GO:0019035 [viral integration complex] GO:0019899 [enzyme binding] GO:0030261 [chromosome condensation] GO:0030263 [apoptotic chromosome condensation] GO:0040016 [embryonic cleavage] GO:0042752 [regulation of circadian rhythm] GO:0042803 [protein homodimerization activity] GO:0042826 [histone deacetylase binding] GO:0043065 [positive regulation of apoptotic process] GO:0043130 [ubiquitin binding] GO:0043234 [protein complex] GO:0044774 [mitotic DNA integrity checkpoint] GO:0044822 [poly(A) RNA binding] GO:0045070 [positive regulation of viral genome replication] GO:0045870 [positive regulation of single stranded viral RNA replication via double stranded DNA intermediate] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046982 [protein heterodimerization activity] GO:0048511 [rhythmic process]